Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis.

Marco Zuin Carlo Cervellati Alessandro Trentini Angelina PassaroValentina RostaFrancesca ZimettiGiovanni Zuliani

Published in: Diagnostics (Basel, Switzerland) (2021)

Our study showed that AD patients present lower serum levels of ApoA-I compared to cognitively normal individuals. Further studies on large population samples are required to support this finding.

Keyphrases

end stage renal disease
newly diagnosed
cognitive decline
ejection fraction
chronic kidney disease
peritoneal dialysis
mild cognitive impairment
patient reported